Reviewed,
UniProtKB/Swiss-Prot P50552 (VASP_HUMAN)
Last modified
November 25, 2008.
Version 89.
History...
Clusters with 100%,
90%,
50% identity |
Documents (4) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Vasodilator-stimulated phosphoprotein Short name=VASP | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 380 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Ena/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance and lamellipodial and filopodial dynamics in migrating cells. VASP promotes actin nucleation and increases the rate of actin polymerization in the presence of capping protein. Plays a role in actin-based activity of Listeria monocytogenes in platelets By similarity. |
| Subunit structure | Homotetramer. Interacts with PFN1, PFN2, LPP, ACTN1 and ACTG1. Interacts, via the EVH1, with the Pro-rich regions of ZYX. This interaction is important for targeting to focal adhesions and the formation of actin-rich structures at the apical surface of cells. Interacts, via the EVH1 domain, with the Pro-rich domain of Listeria monocytogenes actA. Interacts with APBB1IP. Interacts, via the Pro-rich domain, with the C-terminal SH3 domain of DNMBP By similarity. |
| Subcellular location | Cytoplasm. Cytoplasm › cytoskeleton. Cell junction › focal adhesion. Cell projection › lamellipodium membrane. Cell projection › filopodium membrane. Note= Targeted to stress fibers and focal adhesions through interaction with a number of proteins including MRL family members. Localizes to the plasma membrane in protruding lamellipodia and filopodial tips. Stimulation by thrombin or PMA, also translocates VASP to focal adhesions. |
| Tissue specificity | Highly expressed in platelets. |
| Domain | The EVH2 domain is comprised of 3 regions. Block A is a thymosin-like domain required for G-actin binding. The KLKR motif within this block is essential for the G-actin binding and for actin polymerization. Block B is required for F-actin binding and subcellular location, and Block C for tetramerization. The WH1 domain mediates interaction with XIRP1. |
| Post-translational modification | Major substrate for cAMP-dependent (PKA) and cGMP-dependent protein kinase (PKG) in platelets. The preferred site for PKA is Ser-157, the preferred site for PKG, Ser-239. In ADP-activated platelets, phosphorylation by PKA or PKG on Ser-157 leads to fibrinogen receptor inhibition. Phosphorylation on Thr-278 requires prior phosphorylation on Ser-157 and Ser-239. In response to phorbol ester (PMA) stimulation, phosphorylated by PKC/PRKCA. In response to thrombin, phosphorylated by both PKC and ROCK1. |
| Sequence similarities | Belongs to the Ena/VASP family. Contains 1 WH1 domain. |
Ontologies
Keywords | |
|---|---|
| Cellular component | Cell junction Cell membrane Cell projection Cytoplasm Cytoskeleton Membrane |
| Domain | Coiled coil Repeat SH3-binding |
| Ligand | Actin-binding |
| PTM | Acetylation Phosphoprotein |
| Technical term | 3D-structure Direct protein sequencing |
Gene Ontology (GO) | |
| Cellular component | actin cytoskeleton Ref.1 Traceable author statement. Source: ProtInc cytoplasmInferred from electronic annotation. Source: UniProtKB-KW focal adhesionInferred from direct assay. Source: HPA |
| Molecular function | SH3 domain binding Inferred from electronic annotation. Source: UniProtKB-KW actin bindingInferred from electronic annotation. Source: UniProtKB-KW |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed | |||||||||||||||||||||||||||||
| Chain | 2 – 380 | 379 | Vasodilator-stimulated phosphoprotein | PRO_0000065767 | ||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||
| Domain | 2 – 113 | 112 | WH1 | |||||||||||||||||||||||||||||
| Repeat | 344 – 358 | 15 | 1 | |||||||||||||||||||||||||||||
| Repeat | 359 – 373 | 15 | 2 | |||||||||||||||||||||||||||||
| Region | 225 – 377 | 153 | EVH2 | |||||||||||||||||||||||||||||
| Region | 225 – 245 | 21 | EVH2 block A | |||||||||||||||||||||||||||||
| Region | 259 – 278 | 20 | EVH2 block B | |||||||||||||||||||||||||||||
| Region | 343 – 377 | 35 | EVH2 block C | |||||||||||||||||||||||||||||
| Region | 344 – 373 | 30 | 2 X 15 AA tandem repeats of L-[EQ]-[KR]-[MV]-K-[EQ]-E-[IL]-[IL]-E-[AEV]-[FV]-[KRV]-[KQ]-E | |||||||||||||||||||||||||||||
| Coiled coil | 337 – 373 | 37 | Potential | |||||||||||||||||||||||||||||
| Motif | 234 – 237 | 4 | KLKR | |||||||||||||||||||||||||||||
| Compositional bias | 118 – 216 | 99 | Pro-rich | |||||||||||||||||||||||||||||
| Compositional bias | 215 – 222 | 8 | Poly-Gly | |||||||||||||||||||||||||||||
| Compositional bias | 259 – 262 | 4 | Poly-Gly | |||||||||||||||||||||||||||||
| Compositional bias | 322 – 325 | 4 | Poly-Ser | |||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||
| Modified residue | 2 | 1 | N-acetylserine | |||||||||||||||||||||||||||||
| Modified residue | 39 | 1 | Phosphotyrosine | |||||||||||||||||||||||||||||
| Modified residue | 157 | 1 | Phosphoserine; by PKA, PKC, PKG and ROCK1 | |||||||||||||||||||||||||||||
| Modified residue | 239 | 1 | Phosphoserine; by PKA and PKG | |||||||||||||||||||||||||||||
| Modified residue | 278 | 1 | Phosphothreonine; by PKA and PKG | |||||||||||||||||||||||||||||
| Modified residue | 316 | 1 | Phosphothreonine | |||||||||||||||||||||||||||||
| Modified residue | 322 | 1 | Phosphoserine | |||||||||||||||||||||||||||||
| Modified residue | 323 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||
| Mutagenesis | 370 | 1 | F → A: Lower stability of tetramerization domain | |||||||||||||||||||||||||||||
| Mutagenesis | 370 | 1 | F → I or K: No change in stability of tetramerization domain | |||||||||||||||||||||||||||||
| Sequence conflict | 2 | 1 | S → SS in AAH26019. Ref.3 | |||||||||||||||||||||||||||||
| Sequence conflict | 241 | 1 | Missing in AAH26019. Ref.3 | |||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||
| Beta strand | 5 – 12 | 8 | ||||||||||||||||||||||||||||||
| Beta strand | 14 – 16 | 3 | ||||||||||||||||||||||||||||||
| Turn | 18 – 20 | 3 | ||||||||||||||||||||||||||||||
| Beta strand | 25 – 27 | 3 | ||||||||||||||||||||||||||||||
| Beta strand | 34 – 41 | 8 | ||||||||||||||||||||||||||||||
| Turn | 42 – 45 | 4 | ||||||||||||||||||||||||||||||
| Beta strand | 46 – 55 | 10 | ||||||||||||||||||||||||||||||
| Beta strand | 60 – 66 | 7 | ||||||||||||||||||||||||||||||
| Beta strand | 79 – 86 | 8 | ||||||||||||||||||||||||||||||
| Beta strand | 88 – 95 | 8 | ||||||||||||||||||||||||||||||
| Helix | 96 – 114 | 19 | ||||||||||||||||||||||||||||||
| Helix | 226 – 231 | 6 | ||||||||||||||||||||||||||||||
| Helix | 341 – 376 | 36 | ||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular cloning, structural analysis and functional expression of the proline-rich focal adhesion and microfilament-associated protein VASP." Haffner C., Jarchau T., Reinhard M., Hoppe J., Lohmann S.M., Walter U. EMBO J. 14:19-27(1995) [PubMed: 7828592] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 11-32; 87-96; 140-154; 255-282 AND 297-322, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, POSSIBLE FUNCTION. Tissue: Promyelocyte. |
| [2] | "Role of proteins of the Ena/VASP family in actin-based motility of Listeria monocytogenes." Laurent V., Loisel T.P., Harbeck B., Wehman A., Groebe L., Jockusch B.M., Wehland J., Gertler F.B., Carlier M.-F. J. Cell Biol. 144:1245-1258(1999) [PubMed: 10087267] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH L.MONOCYTOGENES ACTA. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Fetal lung, Fetal spleen and Skin. |
| [4] | "Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides." Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R., Vandekerckhove J. Nat. Biotechnol. 21:566-569(2003) [PubMed: 12665801] [Abstract] Cited for: PROTEIN SEQUENCE OF 2-10, ACETYLATION AT SER-2. Tissue: Platelet. |
| [5] | "Cloning of the VASP (vasodilator-stimulated phosphoprotein) genes in human and mouse: structure, sequence, and chromosomal localization." Zimmer M., Fink T., Fischer L., Hauser W., Scherer K., Lichter P., Walter U. Genomics 36:227-233(1996) [PubMed: 8812448] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 3-380. |
| [6] | "cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets." Butt E., Abel K., Krieger M., Palm D., Hoppe V., Hoppe J., Walter U. J. Biol. Chem. 269:14509-14517(1994) [PubMed: 8182057] [Abstract] Cited for: PROTEIN SEQUENCE OF 143-164; 235-244 AND 267-285, PHOSPHORYLATION AT SER-157; SER-239 AND THR-278. |
| [7] | "Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition." Horstrup K., Jablonka B., Honig-Liedl P., Just M., Kochsiek K., Walter U. Eur. J. Biochem. 225:21-27(1994) [PubMed: 7925440] [Abstract] Cited for: PHOSPHORYLATION AT SER-157, FIBRINOGEN RECEPTOR INHIBITION. |
| [8] | "The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins." Reinhard M., Giehl K., Abel K., Haffner C., Jarchau T., Hoppe V., Jockusch B.M., Walter U. EMBO J. 14:1583-1589(1995) [PubMed: 7737110] [Abstract] Cited for: INTERACTION WITH ACTG1 AND PFN1. |
| [9] | "The EVH2 domain of the vasodilator-stimulated phosphoprotein mediates tetramerization, F-actin binding, and actin bundle formation." Bachmann C., Fischer L., Walter U., Reinhard M. J. Biol. Chem. 274:23549-23557(1999) [PubMed: 10438535] [Abstract] Cited for: FUNCTION OF EVH2 DOMAIN. |
| [10] | "Characterization of the interaction between zyxin and members of the Ena/vasodilator-stimulated phosphoprotein family of proteins." Drees B., Friederich E., Fradelizi J., Louvard D., Beckerle M.C., Golsteyn R.M. J. Biol. Chem. 275:22503-22511(2000) [PubMed: 10801818] [Abstract] Cited for: INTERACTION WITH ZYX. |
| [11] | "LPP, an actin cytoskeleton protein related to zyxin, harbors a nuclear export signal and transcriptional activation capacity." Petit M.M., Fradelizi J., Golsteyn R.M., Ayoubi T.A., Menichi B., Louvard D., Van de Ven W.J.M., Friederich E. Mol. Biol. Cell 11:117-129(2000) [PubMed: 10637295] [Abstract] Cited for: INTERACTION WITH LPP. |
| [12] | "Lamellipodin, an Ena/VASP ligand, is implicated in the regulation of lamellipodial dynamics." Krause M., Leslie J.D., Stewart M., Lafuente E.M., Valderrama F., Jagannathan R., Strasser G.A., Rubinson D.A., Liu H., Way M., Yaffe M.B., Boussiotis V.A., Gertler F.B. Dev. Cell 7:571-583(2004) [PubMed: 15469845] [Abstract] Cited for: INTERACTION WITH RAPH1. |
| [13] | "Vasodilator-stimulated phosphoprotein is a substrate for protein kinase C." Chitaley K., Chen L., Galler A., Walter U., Daum G., Clowes A.W. FEBS Lett. 556:211-215(2004) [PubMed: 14706852] [Abstract] Cited for: PHOSPHORYLATION BY PKC. |
| [14] | "Ena/VASP proteins enhance actin polymerization in the presence of barbed end capping proteins." Barzik M., Kotova T.I., Higgs H.N., Hazelwood L., Hanein D., Gertler F.B., Schafer D.A. J. Biol. Chem. 280:28653-28662(2005) [PubMed: 15939738] [Abstract] Cited for: FUNCTION. |
| [15] | "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells." Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.-M., Polakiewicz R.D., Comb M.J. Nat. Biotechnol. 23:94-101(2005) [PubMed: 15592455] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-39, MASS SPECTROMETRY. |
| [16] | "Vasodilator-stimulated phosphoprotein (VASP) is phosphorylated on Ser 157 by protein kinase C-dependent and -independent mechanisms in thrombin-stimulated human platelets." Wentworth J.K., Pula G., Poole A.W. Biochem. J. 393:555-564(2006) [PubMed: 16197368] [Abstract] Cited for: PHOSPHORYLATION AT SER-157, SUBCELLULAR LOCATION. |
| [17] | "Unusual splicing events result in distinct Xin isoforms that associate differentially with filamin c and Mena/VASP." van der Ven P.F.M., Ehler E., Vakeel P., Eulitz S., Schenk J.A., Milting H., Micheel B., Fuerst D.O. Exp. Cell Res. 312:2154-2167(2006) [PubMed: 16631741] [Abstract] Cited for: INTERACTION WITH XIRP1. |
| [18] | "Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer." Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M. Comb M.J.Cell 131:1190-1203(2007) [PubMed: 18083107] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-39, MASS SPECTROMETRY. |
| [19] | "Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry." Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239, MASS SPECTROMETRY. |
| [20] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-316 AND SER-322, MASS SPECTROMETRY. |
| [21] | "The VASP tetramerization domain is a right-handed coiled coil based on a 15-residue repeat." Kuehnel K., Jarchau T., Wolf E., Schlichting I., Walter U., Wittinghofer A., Strelkov S.V. Proc. Natl. Acad. Sci. U.S.A. 101:17027-17032(2004) [PubMed: 15569942] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 336-380, TETRAMERIZATION, MUTAGENESIS OF PHE-370. |
| [22] | "Dual epitope recognition by the VASP EVH1 domain modulates polyproline ligand specificity and binding affinity." Ball L.J., Kuehne R., Hoffmann B., Haefner A., Schmieder P., Volkmer-Engert R., Hof M., Wahl M., Schneider-Mergener J., Walter U., Oschkinat H., Jarchau T. EMBO J. 19:4903-4914(2000) [PubMed: 10990454] [Abstract] Cited for: STRUCTURE BY NMR OF 1-115. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Z46389 mRNA. Translation: CAA86523.1. BC026019 mRNA. Translation: AAH26019.1. BC038224 mRNA. Translation: AAH38224.1. X98534, X98533 Genomic DNA. Translation: CAA67147.2. | |||||||||||||||||||||||||||||||||||||||||||
| PIR | S51797. | ||||||||||||||||||||||||||||||||||||||||||
| RefSeq | NP_003361.1. | ||||||||||||||||||||||||||||||||||||||||||
| UniGene | Hs.702197 | ||||||||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||||||||||||||
| IntAct | P50552. | ||||||||||||||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||||||||||||||
| PhosphoSite | P50552. | ||||||||||||||||||||||||||||||||||||||||||
2-D gel databases | |||||||||||||||||||||||||||||||||||||||||||
| OGP | P50552. | ||||||||||||||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||||||||||||||
| PeptideAtlas | P50552. | ||||||||||||||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||||||||||||||
| Ensembl | ENSG00000125753. Homo sapiens. [Contig view] | ||||||||||||||||||||||||||||||||||||||||||
| GeneID | 7408. | ||||||||||||||||||||||||||||||||||||||||||
| KEGG | hsa:7408. | ||||||||||||||||||||||||||||||||||||||||||
| NMPDR | fig|9606.3.peg.16699. | ||||||||||||||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||||||||||||||
| H-InvDB | HIX0027641. | ||||||||||||||||||||||||||||||||||||||||||
| HGNC | HGNC:12652. VASP. | ||||||||||||||||||||||||||||||||||||||||||
| HPA | CAB004612. HPA005724. | ||||||||||||||||||||||||||||||||||||||||||
| MIM | 601703. gene. | ||||||||||||||||||||||||||||||||||||||||||
| PharmGKB | PA37276. | ||||||||||||||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||||||||||||||
| GeneCards | Search... | ||||||||||||||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||||||||||||||
| HOGENOM | P50552. | ||||||||||||||||||||||||||||||||||||||||||
| HOVERGEN | P50552. | ||||||||||||||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||||||||||||||
| CleanEx | |||||||||||||||||||||||||||||||||||||||||||

Clusters with